If left untreated, CKD can progress to kidney failure and early cardiovascular disease. When the kidneys stop working, dialysis or kidney transplant is needed for survival. Kidney failure treated with dialysis or kidney transplant is called end-stage renal disease (ESRD).
This report contains market size and forecasts of CKD and ESRD Treatment in Global, including the following market information:
Global CKD and ESRD Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global CKD and ESRD Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Medicine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of CKD and ESRD Treatment include Fresenius, DaVita, Baxter, Nipro, B. Braun, Asahi Kasei, Nikkiso, WEGO and Newsol, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CKD and ESRD Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CKD and ESRD Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global CKD and ESRD Treatment Market Segment Percentages, by Type, 2021 (%)
Medicine
Hemodialysis
Peritoneal Dialysis
Kidney Transplantation
Global CKD and ESRD Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global CKD and ESRD Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Kidney Dialysis Centers
At Homes
Others
Global CKD and ESRD Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global CKD and ESRD Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CKD and ESRD Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies CKD and ESRD Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
Nikkiso
WEGO
Newsol
Mayo Clinic
Guangdong Biolight
Medtronic
Sanxin Medtec
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
AstraZeneca
Vifor Pharma